Matt Levy

In this video, I talk about some different features of various state patent troll laws. Below the video I've listed all the states with each feature. https://youtu.be/r5ADQZrlFmM States with a...

(cross-posted from IP Watchdog) I’ll be speaking on November 17, 2015 at IAM’s Patent Law and Policy event. (It looks to be a really interesting day.) My panel has the provocative title, “Death...

As I’ve written before, inter partes review (IPR) has been a sticking point in patent reform. Some practitioners have complained that the current process for amending claims is too complicated and u...

I was on a panel the other day discussing patent reform, and a funny thing happened. While we disagreed about a number of aspects of patent reform, basically everyone on the panel agreed that it’s r...

Kyle Bass has lost another one of his inter partes review petitions. (If you need reminding who Kyle Bass is, see here and here.) I'm on a panel this coming Tuesday (9/8/2015) with a couple of p...

I've written about [define term="inter partes review"] a number of times (e.g., here, here, and here) because it's an incredibly useful tool for dealing with bad patents. Now, Scott Graham and Lisa Sh...

Kyle Bass, the hedge fund manager who filed a number of inter partes review petitions against pharmaceutical companies, has struck terror into the shriveled hearts of the pharmaceutical industry. The ...

Here's a video I've done to explain why the pharmaceutical companies' campaign against inter partes review is disingenuous at best: You can read more about IPRs here. Note: There was a comment on T...

We hear the same complaints over and over every time Congress tries to improve the patent system. In fact, we’ve been hearing some of them for over 70 years. Here’s a little quiz to illustrate th...